Analysts Are Bullish on Top Healthcare Stocks: Third Harmonic Bio, Inc. (THRD), Treace Medical Concepts (TMCI)
Morgan Stanley Maintains Equal-Weight on Third Harmonic Bio, Raises Price Target to $7
Third Harmonic Bio Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Third Harmonic Bio, Inc. (THRD) and Verve Therapeutics (VERV)
LifeSci Capital Upgrades Third Harmonic Bio, Inc. (THRD) to a Buy
LifeSci Capital Sticks to Its Hold Rating for Third Harmonic Bio, Inc. (THRD)
LifeSci Capital Keeps Their Hold Rating on Third Harmonic Bio, Inc. (THRD)
Third Harmonic Bio Analyst Ratings
Jefferies Downgrades Third Harmonic Bio to Hold, Lowers Price Target to $3.6
Third Harmonic Bio, Inc. (THRD) Has a New Rating From Jefferies
Morgan Stanley Starts Third Harmonic Bio at Overweight With $34 Price Target
Third Harmonic Bio Analyst Ratings
No Data